Pensioenfonds Rail & OV bought a new stake in shares of Stryker Corporation (NYSE:SYK – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 20,841 shares of the medical technology company’s stock, valued at approximately $5,739,000. Stryker comprises approximately 1.5% of Pensioenfonds Rail & OV’s investment portfolio, making the stock its 24th biggest holding.
Several other hedge funds and other institutional investors also recently bought and sold shares of SYK. Gables Capital Management Inc. bought a new position in Stryker during the second quarter valued at $25,000. Kilter Group LLC bought a new stake in shares of Stryker in the 2nd quarter worth about $25,000. Cornerstone Financial Management LLC lifted its holdings in shares of Stryker by 66.0% in the 2nd quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock worth $25,000 after acquiring an additional 31 shares during the last quarter. Highland Investment Advisors LLC bought a new stake in shares of Stryker in the 2nd quarter worth about $25,000. Finally, Compass Financial Management LLC purchased a new position in shares of Stryker during the 2nd quarter worth about $27,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.
Insider Activity at Stryker
In related news, Director Ronda E. Stryker sold 550,000 shares of Stryker stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $325.32, for a total transaction of $178,926,000.00. Following the completion of the transaction, the director directly owned 1,701,375 shares in the company, valued at approximately $553,491,315. This trade represents a 24.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Debra King sold 826 shares of Stryker stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the transaction, the insider directly owned 6,210 shares of the company’s stock, valued at approximately $2,088,423. This trade represents a 11.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 901,267 shares of company stock worth $297,123,701 over the last quarter. Insiders own 4.60% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on SYK. Evercore increased their price objective on shares of Stryker from $335.00 to $355.00 in a research report on Wednesday, October 28th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Stryker in a research note on Wednesday, October 7th. BMO Capital Markets reaffirmed an “outperform” rating and set a $309.00 target price (down from $317.00) on shares of Stryker in a research note on Friday, October 30th. BTIG Research reduced their price target on Stryker from $316.00 to $304.00 and set a “buy” rating on the stock in a report on Friday, October 30th. Finally, Needham & Company LLC decreased their price target on Stryker from $418.00 to $359.00 and set a “buy” rating for the company in a research note on Friday, October 30th. Twenty-one investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, Stryker presently has an average rating of “Moderate Buy” and a consensus target price of $342.19.
Get Our Latest Analysis on SYK
Stryker Stock Down 1.1%
Shares of NYSE SYK traded down $3.34 during trading hours on Friday, hitting $309.05. 3,251,740 shares of the stock were exchanged, compared to its average volume of 3,235,306. The company has a quick ratio of 1.30, a current ratio of 2.18 and a debt-to-equity ratio of 0.60. The company has a market cap of $117.65 billion, a PE ratio of 32.91, a PEG ratio of 2.14 and a beta of 0.78. The firm has a fifty day moving average price of $292.30 and a 200-day moving average price of $322.60. Stryker Corporation has a 12 month low of $267.00 and a 12 month high of $389.33.
Stryker (NYSE:SYK – Get Free Report) last released its quarterly earnings results on Thursday, October 29th. The medical technology company reported $3.52 EPS for the quarter, missing analysts’ consensus estimates of $3.55 by ($0.03). The business had revenue of $6.52 billion during the quarter, compared to analysts’ expectations of $6.62 billion. Stryker had a net margin of 13.78% and a return on equity of 23.74%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $3.19 earnings per share. On average, sell-side analysts expect that Stryker Corporation will post 14.85 EPS for the current year.
Stryker Profile
Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.
Recommended Stories
- Five stocks we like better than Stryker
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
